ClassID:

97074

C07K14/78 - page 5 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Recent Application in this class:
#1201
20130157257
2013-06-20

Compositions comprising the NC2 domain of collagen IX and methods of using same

#1202
20130150305
2013-06-13

Method for promoting wound healing

#1203
20130150300
2013-06-13

Specific binding sites in collagen for integrins and use thereof

#1204
20130137639
2013-05-30

Stable MIA/CD-RAP formulation

#1205
20130130384
2013-05-23

Temperature responsive sheet that displays reversible properties and cell sheet production method using same

#1206
20130130349
2013-05-23

COOPERATIVE AND DYNAMIC ASSEMBLY OF AFFINITY COMPLEXES

#1207
20130129710
2013-05-23

HEMOSTATIC COMPOSITIONS

#1208
20130122028
2013-05-16

NOVEL VACCINE THAT TARGETS TUMOR VESSELS AS AN EFFICIENT TOOL IN TUMOR THERAPY

#1209
20130116405
2013-05-09

Compositions comprising modified collagen and uses therefor

#1210
20130116189
2013-05-09

Retinol-modified collagen, method for producing same, and external composition for skin containing same

#1211
20130096058
2013-04-18

TRAIL R2-specific multimeric scaffolds

#1212
20130096019
2013-04-18

Fibronectin type III domain based scaffold compositions, methods and uses

#1213
20130090455
2013-04-11

TRANSFORMANT WHICH PRODUCES GLYCINE REPEAT SEQUENCE PROTEIN

#1214
20130085104
2013-04-04

THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

#1215
20130085099
2013-04-04

Therapeutic agents comprising insulin and elastin-like peptides

#1216
20130079496
2013-03-28

COLLAGEN MIXTURE AND METHOD OF MAKING THE SAME

#1217
20130079495
2013-03-28

Collagen fibrillar construction

#1218
20130079277
2013-03-28

Methods of treating diabetes using therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptides

#1219
20130074199
2013-03-21

Compositions and methods for brown fat induction and activity using FNDC5

#1220
20130071645
2013-03-21

METHOD FOR SEPARATING ATELOCOLLAGEN, METHOD FOR PREPARING MODIFIED ATELOCOLLAGEN, ATELOCOLLAGEN PREPARED BY USING THE SAME AND COLLAGEN-BASED MATRIX

#1221
20130071441
2013-03-21

Cell construct for cell transplantation and cell aggregate for cell transplantation

#1222
20130071362
2013-03-21

Human placental collagen compositions, and methods of making and using the same

#1223
20130059901
2013-03-07

Pre-MRNA trans-splicing molecule (RTM) molecules and their uses

#1224
20130059786
2013-03-07

Kit for detecting Cthrc1 in a sample

#1225
20130058991
2013-03-07

Matricryptic ECM peptides for tissue reconstruction

#1226
20130053595
2013-02-28

CATALYST AND PROCESS FOR PREPARING ACROLEIN AND/OR ACRYLIC ACID BY DEHYDRATION REACTION OF GLYCERIN

#1227
20130045923
2013-02-21

COLLAGENOUS MATERIAL

#1228
20130045212
2013-02-21

Biological Materials and Uses Thereof

#1229
20130040891
2013-02-14

Chemically modified water-soluble elastin, mixed gel of chemically modified water-soluble elastin and collagen, and process for producing same

#1230
20130040885
2013-02-14

COLLAGEN PAD

#1231
20130039878
2013-02-14

Triple cross-linked collagen, method of manufacturing the same, and use thereof

#1232
20130034552
2013-02-07

Temperature sensitive conjugate compositions

#1233
20130030526
2013-01-31

Crosslinked human or animal tissue products and their methods of manufacture and use

#1234
20130030153
2013-01-31

Crosslinked human or animal tissue products and their methods of manufacture and use

#1235
20130029915
2013-01-31

Crosslinked human or animal tissue products and their methods of manufacture and use

#1236
20130028949
2013-01-31

Cosmetic sponge and method for providing a cosmetic sponge

#1237
20130023648
2013-01-24

Controlled cross-linking processing of proteins

#1238
20130018463
2013-01-17

COLLAGEN FIBER CONSTRUCTS FOR REPLACING CRUCIATE LIGAMENTS

#1239
20130012436
2013-01-10

Fibronectin based scaffold domain proteins that bind IL-23

#1240
20130012435
2013-01-10

Multivalent fibronectin based scaffold domain proteins

#1241
20130011451
2013-01-10

FOOTBED WITH NON-DENATURED COLLAGEN

#1242
20130005664
2013-01-03

THERAPEUTIC AGENTS COMPRISING ELASTIC PEPTIDES

#1243
20130004543
2013-01-03

Fibronectin: growth factor chimeras

#1244
20120329670
2012-12-27

EPITOPE TESTING USING SOLUBLE HLA

#1245
20120329080
2012-12-27

ANTI-HLA ASSAY AND METHODS

#1246
20120328690
2012-12-27

Amniotic membrane preparations and purified compositions and anti-inflammation methods

#1247
20120322107
2012-12-20

Methods of increasing the expression yield of vitamin K-dependent proteins

#1248
20120321624
2012-12-20

Targeting the neuromuscular junction for treatment

#1249
20120309939
2012-12-06

Production of Therapeutic Proteins in Photosynthetic Organisms

#1250
20120308611
2012-12-06

Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials

#1251
20120302512
2012-11-29

Isolated laminin-421

#1252
20120302452
2012-11-29

COMPARATIVE LIGAND MAPPING FROM MHC CLASS I POSITIVE CELLS

#1253
20120301962
2012-11-29

Vitronectin-derived cell culture substrate and uses thereof

#1254
20120301871
2012-11-29

COMPARATIVE LIGAND MAPPING FROM MHC POSITIVE CELLS

#1255
20120295957
2012-11-22

Prevention of tissue ischemia and related compositions

#1256
20120295956
2012-11-22

Prevention of tissue ischemia and related methods

#1257
20120294902
2012-11-22

Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope

#1258
20120284817
2012-11-08

COLLAGEN PRODUCING PLANTS AND METHODS OF GENERATING AND USING SAME

#1259
20120283184
2012-11-08

Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides

#1260
20120276559
2012-11-01

Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents

#1261
20120276039
2012-11-01

Aptamer-modified polymeric materials for the binding of factors in a wound environment

#1262
20120271124
2012-10-25

Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents

#1263
20120270810
2012-10-25

Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices

#1264
20120270797
2012-10-25

ENGINEERED PROTEINS INCLUDING MUTANT FIBRONECTIN DOMAINS

#1265
20120270770
2012-10-25

Anti-angiogenic peptides and their uses

#1266
20120269880
2012-10-25

Purified amniotic membrane compositions and methods of use

#1267
20120263747
2012-10-18

Albumin-Fused Anti-Angiogenesis Peptides

#1268
20120245327
2012-09-27

TRANSFORMANT WHICH PRODUCES COLLAGEN WHEREIN BOTH LYSINE RESIDUE AND PROLINE RESIDUE ARE HYDROXYLATED

#1269
20120237535
2012-09-20

Therapeutic Compositions For The Treatment of HPV-Induced Diseases

#1270
20120237495
2012-09-20

Method of treatment using solubilized protein composition obtained from eggshell membrane

#1271
20120232012
2012-09-13

Compositions having antiangiogenic activity and uses thereof

#1272
20120230977
2012-09-13

Flowable collagen-based hemostat and methods of use

#1273
20120225484
2012-09-06

Human placental collagen compositions, and methods of making and using the same

#1274
20120220536
2012-08-30

Use of endostatin peptides for the treatment of fibrosis

#1275
20120213781
2012-08-23

Monovalent and Multivalent Multispecific Complexes and Uses Thereof

#1276
20120213763
2012-08-23

Mutants of Streptokinase and their covalently modified forms

#1277
20120213752
2012-08-23

ISOLATED STROMAL CELLS AND METHODS OF USING THE SAME

#1278
20120208768
2012-08-16

SPECIFIC BINDING SITES IN COLLAGEN FOR INTEGRINS AND USE THEREOF

#1279
20120208761
2012-08-16

Type I-type IV collagen hybrid gel

#1280
20120208742
2012-08-16

Compositions of a peptide targeting system for treating cancer

#1281
20120207848
2012-08-16

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#1282
20120202263
2012-08-09

Bioactive Macromers and Hydrogels and Methods for Producing Same

#1283
20120201858
2012-08-09

Multiple-arm peptide compounds, methods of manufacture and use in therapy

#1284
20120196807
2012-08-02

KIDNEY-TARGETING DRUG DELIVERY AGENT COMPRISING RECOMBINANT GELATIN

#1285
20120195828
2012-08-02

Kidney-imaging agent comprising recombinant gelatin

#1286
20120190612
2012-07-26

METHODS OF TREATMENT

#1287
20120174244
2012-07-05

Profiling fragments of elastic fibers and microfibrils as biomarkers for disease

#1288
20120172577
2012-07-05

Methods of producing proteins having triple-helix structure

#1289
20120171170
2012-07-05

TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE

#1290
20120165263
2012-06-28

Bone regeneration agent comprising gelatin

#1291
20120157393
2012-06-21

Biopolymer, implant comprising it and uses thereof

#1292
20120156782
2012-06-21

Cell culture medium

#1293
20120156276
2012-06-21

Connective tissue stimulating peptides

#1294
20120156254
2012-06-21

Recombinant laminin-521

#1295
20120156132
2012-06-21

Targeting agent to newly formed blood vessels

#1296
20120149871
2012-06-14

Synthetic, defined fibronectin mimetic peptides and surfaces modified with the same

#1297
20120148614
2012-06-14

Interaction of with epithelial cells, extracellular matrix proteins and the complement system

#1298
20120147987
2012-06-14

Method and apparatus for data transmission using multiple transmit antennas

#1299
20120141707
2012-06-07

Biphasic Collagen Membrane or Capsule for Guided Tissue Regeneration

#1300
20120141417
2012-06-07

Collagen preparation and method of isolation

#1301
20120135516
2012-05-31

Artificial antibody polypeptides

#1302
20120130046
2012-05-24

Tropoelastin derivatives

#1303
20120121793
2012-05-17

Nanoscale collagen particles and membranes

#1304
20120121709
2012-05-17

Phase transition biopolymers and methods of use

#1305
20120121682
2012-05-17

cRGD peptide derivative and its manufacture, and implant having a coating containing a cRGD peptide derivative

#1306
20120116346
2012-05-10

HYPERTHERMIA INDUCED DEPOSITION OF ELASTIN FIBERS

#1307
20120116053
2012-05-10

Expression of triple-helical collagen-like products in

#1308
20120115797
2012-05-10

Peptide compositions that bind TLR-4

#1309
20120114617
2012-05-10

Peptide promoting cell adhesion and migration

#1310
20120114570
2012-05-10

COLLAGEN EXTRACTION FROM AQUATIC ANIMALS

#1311
20120107372
2012-05-03

Recombinant gelatins

#1312
20120094909
2012-04-19

Fibronectin based scaffold domain proteins that bind to PCSK9

#1313
20120093740
2012-04-19

Peptide fragments for inducing synthesis of extracellular matrix proteins

#1314
20120083445
2012-04-05

Compositions containing HC-HA complex and methods of use thereof

#1315
20120077870
2012-03-29

Materials and methods for the treatment of pathological neovascularization in the eye

#1316
20120065376
2012-03-15

Methods of processing recombinant procollagen

#1317
20120059152
2012-03-08

Protein substance having triple helix structure and manufacturing method therefor

#1318
20120058138
2012-03-08

Adenovirus vectors

#1319
20120045781
2012-02-23

Pathology biomarker assay

#1320
20120040900
2012-02-16

Compositions of and methods of using ligand dimers

#1321
20120040119
2012-02-16

Collagen materials and methods for obtaining same

#1322
20120040055
2012-02-16

COLLAGEN PEPTIDE COMPOSITION HAVING GOOD ABILITY TO ENTER THE BLOOD AND FOOD OR BEVERAGE CONTAINING THE SAME

#1323
20120039801
2012-02-16

SPARC binding peptides and uses thereof

#1324
20120034229
2012-02-09

Monoclonal antibodies directed against LG4-5 domain of alpha3 chain of human laminin-5

#1325
20120028903
2012-02-02

Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor

#1326
20120027732
2012-02-02

THERMOREVERSIBLE COLLAGEN

#1327
20120014954
2012-01-19

SPARC binding ScFvs

#1328
20120003283
2012-01-05

Injectable biomaterials

#1329
20120003201
2012-01-05

VAULT AGENTS FOR CHRONIC KIDNEY DISEASE

#1330
20110312893
2011-12-22

METHOD FOR ISOLATING NEURAL CELLS WITH TENASCIN-R COMPOUNDS

#1331
20110312891
2011-12-22

ENAMEL MATRIX DERIVATIVE FRACTION C

#1332
20110312027
2011-12-22

Production of carrier-peptide conjugates using chemically reactive unnatural amino acids

#1333
20110306755
2011-12-15

Human placental collagen compositions and methods of making and using the same

#1334
20110305663
2011-12-15

Serum albumin binding molecules

#1335
20110300130
2011-12-08

IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS

#1336
20110294192
2011-12-01

FUSION COLLAGENASE IN WHICH AFFINITY TAG IS LINKED AND METHOD FOR PRODUCING THE SAME

#1337
20110288274
2011-11-24

Designer collagens and use thereof

#1338
20110288026
2011-11-24

Electroprocessed collagen and tissue engineering

#1339
20110282032
2011-11-17

Process for highly selective purification of two plasma proteins: von willebrand factor (vWF) and fibronectin (Fn)

#1340
20110280841
2011-11-17

Electroprocessing in Drug Delivery and Cell Encapsulation

#1341
20110275788
2011-11-10

Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials

#1342
20110275535
2011-11-10

Yeast Display Systems

#1343
20110274623
2011-11-10

Stabilized fibronectin domain compositions, methods and uses

#1344
20110262541
2011-10-27

Foam-formed collagen strand

#1345
20110256222
2011-10-20

Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site

#1346
20110236974
2011-09-29

Compositions and methods for making and using laminin nanofibers

#1347
20110236384
2011-09-29

DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS

#1348
20110212448
2011-09-01

GAMMACARBOXYGLUTAMATE-RICH PROTEIN, METHODS AND ASSAYS FOR ITS DETECTION, PURIFICATION AND QUANTIFICATION AND USES THEREOF

#1349
20110207671
2011-08-25

METHOD FOR PRODUCING DOUBLE-CROSSLINKED COLLAGEN

#1350
20110207669
2011-08-25

Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation

#1351
20110189124
2011-08-04

Method for preparing recombinant granulocyte colony stimulating factor cysteine muteins

#1352
20110183418
2011-07-28

Peptide-Polymer Cell Culture Articles and Methods of Making

#1353
20110182921
2011-07-28

REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF

#1354
20110177998
2011-07-21

Bioactive peptides and methods of using same

#1355
20110172159
2011-07-14

PROTEIC ACID POLYMER, PRODUCTION PROCESSES, USE OF PROTEIC ACID POLYMER, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT

#1356
20110166325
2011-07-07

Collagen fibrillar construction

#1357
20110165176
2011-07-07

Aldosterone induced vascular elastin production

#1358
20110151563
2011-06-23

Collagen materials, films and methods of making same

#1359
20110150875
2011-06-23

Method of reducing total cholesterol level by administering matrilin-2 polypeptide

#1360
20110144310
2011-06-16

Diagnosis of collagen IX destruction

#1361
20110143963
2011-06-16

Molecular affinity clamp technology and uses thereof

#1362
20110137013
2011-06-09

Collagen-like protein CLAC, a precursor thereof, and genes encoding the same

#1363
20110135641
2011-06-09

Radioprotectants targeting thrombospondin-1 and CD47

#1364
20110124527
2011-05-26

Universal fibronectin type III binding-domain libraries

#1365
20110123545
2011-05-26

COMBINATION OF VEGFR2 AND IGF1R INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#1366
20110123487
2011-05-26

Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides

#1367
20110120876
2011-05-26

Conversion coating for aluminum and its alloys and articles thereof

#1368
20110118437
2011-05-19

Process for the synthesis of cyclic heptapeptide

#1369
20110117658
2011-05-19

METHOD OF RATIONAL-BASED DRUG DESIGN USING OSTEOCALCIN

#1370
20110111003
2011-05-12

Stable cell binding chimeric peptides

#1371
20110108644
2011-05-12

Method of making demineralized bone particles

#1372
20110105408
2011-05-05

THERAPEUTIC PEPTIDES

#1373
20110104225
2011-05-05

Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair

#1374
20110097709
2011-04-28

Method for modifying a nucleic acid

#1375
20110092441
2011-04-21

Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component

#1376
20110092422
2011-04-21

Elastin based growth factor delivery platform for wound healing and regeneration

#1377
20110083199
2011-04-07

Transgenic mouse comprising a disrupted Fibulin-4 gene as a model for cardiovascular disease

#1378
20110077382
2011-03-31

Collagen peptide having immune-enhancing activity from and preparation method and uses thereof

#1379
20110076708
2011-03-31

Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions

#1380
20110076234
2011-03-31

PEPTIDES COMPRISING AN ISODGR MOTIF

#1381
20110070253
2011-03-24

TUMOUR-ASSOCIATED PEPTIDES BINDING TO MHC MOLECULES

#1382
20110065587
2011-03-17

EPITOPE TESTING USING SOLUBLE HLA

#1383
20110065206
2011-03-17

Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents

#1384
20110065177
2011-03-17

Novel Collectin

#1385
20110065124
2011-03-17

Methods of identifying compounds that bind TANGO509

#1386
20110055940
2011-03-03

Polynucleotides encoding therapeutic inhibitors of PAI-1

#1387
20110053842
2011-03-03

Targeted therapeutics based on engineered proteins that bind EGFR

#1388
20110039776
2011-02-17

FUSION PEPTIDE THERAPEUTIC COMPOSITIONS

#1389
20110038914
2011-02-17

Coral-derived collagen and methods of farming same

#1390
20110038866
2011-02-17

Fibronectin-based binding molecules and uses thereof

#1391
20110038865
2011-02-17

ANTIBODY- ENDOSTATIN FUSION PROTEIN AND ITS VARIANTS

#1392
20110034401
2011-02-10

Process for solubilizing protein from a proteinaceous material and compositions thereof

#1393
20110034384
2011-02-10

COMBINATION VEGFR2 THERAPY WITH mTOR INHIBITORS

#1394
20110033440
2011-02-10

Solubilized protein composition obtained from avian eggshell membrane

#1395
20110021753
2011-01-27

Method for preparing porous collagen matrices

#1396
20110021752
2011-01-27

Tropoelastin Derivatives

#1397
20110021746
2011-01-27

Universal fibronectin type III binding-domain libraries

#1398
20110020864
2011-01-27

Preparation of high purity collagen

#1399
20110020298
2011-01-27

Collagen-binding synthetic peptidoglycans, preparation, and methods of use

#1400
20110014218
2011-01-20

IXODES SCAPULARIS SALIVARY PROTEINS AND METHODS OF USE FOR MODULATION OF THE ALTERNATIVE COMPLEMENT PATHWAY

#1401
20110008890
2011-01-13

Self-assembly of peptide-amphiphile nanofibers under physiological conditions

#1402
20110008366
2011-01-13

Inhibition of versican with siRNA and other molecules

#1403
20110008340
2011-01-13

Anti-properdin antibodies

#1404
20110003970
2011-01-06

MULTI BLOCK COPOLYMERS

#1405
20100331396
2010-12-30

Neostatins

#1406
20100331257
2010-12-30

PREPARATION OF TERMINALLY-STERILIZED COLLAGEN THAT IS SOLUBLE AT NEUTRAL PH

#1407
20100331253
2010-12-30

METHOD FOR CELL ADHESION AND WOUND HEALING

#1408
20100323455
2010-12-23

Diagnostic assay for human matrix GLA-protein and its use as a biomarker

#1409
20100323377
2010-12-23

Biochemical markers for CVD risk assessment

#1410
20100316616
2010-12-16

Use of FZC18-Containing Collagen 18 Polypeptides for the Treatment, Diagnosis and Outcome Prediction of Diseases

#1411
20100311640
2010-12-09

Self-assembling peptide incorporating modifications and methods of use thereof

#1412
20100310658
2010-12-09

Electroprocessed Fibrin-Based Matrices and Tissues

#1413
20100310549
2010-12-09

Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors

#1414
20100305039
2010-12-02

Production of collagen in the milk of transgenic mammals

#1415
20100298541
2010-11-25

Protein scaffolds

#1416
20100297693
2010-11-25

Production of carrier-peptide conjugates using chemically reactive unnatural amino acids

#1417
20100292161
2010-11-18

Polypeptides and methods of use

#1418
20100291080
2010-11-18

Compositions and methods for tissue repair

#1419
20100291058
2010-11-18

Sealants for Skin and Other Tissues

#1420
20100286368
2010-11-11

Polypeptide and process for producing the same

#1421
20100286253
2010-11-11

Method for treating ocular neovascularization

#1422
20100285103
2010-11-11

MEDICAMENT FOR TREATMENT OF TUMORS AND THE USE THEREOF

#1423
20100280226
2010-11-04

Method for using nano carbon to refine collagen into nanoparticulate collagen

#1424
20100279940
2010-11-04

CHIMERIC OSTEOGENIC FACTOR CONTAINING PROTEINS CAPABLE OF INCREASED NUCLEAR LOCALIZATION AND METHODS OF USE THEREOF

#1425
20100279927
2010-11-04

Method of treating a disease or condition characterized by aberrant epithelial cell proliferation

#1426
20100273215
2010-10-28

Secretion Yield of a Protein of Interest by in vivo Proteolytic Processing of a Multimeric Precursor

#1427
20100272812
2010-10-28

RGD-MODIFIED ALGINATE MICROPARTICLES AS A DRUG RELEASE SYSTEM

#1428
20100272644
2010-10-28

Complexation of fatty acid-conjugated molecules with albumin

#1429
20100266661
2010-10-21

Osteogenic implants with combined implant materials and methods for same

#1430
20100266660
2010-10-21

Osteogenic implants with combined implant materials and methods for same

#1431
20100266658
2010-10-21

Osteogenic implants with combined implant materials and methods for same

#1432
20100263061
2010-10-14

Properdin Modulation of Alternative Pathway and Uses Thereof

#1433
20100256075
2010-10-07

High Yield Secretion of Multimeric Recombinant Protein

#1434
20100255578
2010-10-07

Method of producing lymphocytes

#1435
20100255457
2010-10-07

Method for obtaning thin fibril collagen by contacting native collagen with an antibody

#1436
20100255056
2010-10-07

Fibronectin type III domain based scaffold compositions, methods and uses

#1437
20100255003
2010-10-07

Immune disease medicament comprising a modulator of the binding between a heparin binding domain of thrombospondin-1 and a beta1 integrin

#1438
20100247529
2010-09-30

COOPERATIVE AND DYNAMIC ASSEMBLY OF AFFINITY COMPLEXES

#1439
20100239545
2010-09-23

Methods of expressing LIM mineralization protein in non-osseous cells

#1440
20100233737
2010-09-16

MARKER SPECIFIC TO AN OXIDATIVE DEGRADATION OF TISSUES CONTAINING TYPE III COLLAGEN, MEANS AND METHODS AND KITS FOR THE DIAGNOSIS, MONITORING OR PROGNOSIS OF PATHOLOGIES TARGETED BY THIS MARKER

#1441
20100233242
2010-09-16

Engineered proteins, and methods of making and using

#1442
20100222549
2010-09-02

DECHALCOGENATIVE METHODS FOR THE PREPARATION OF ALLYLIC SULFIDES

#1443
20100222264
2010-09-02

Use of RGD-enriched gelatine-like proteins for inhibition of cancer metastasis

#1444
20100221224
2010-09-02

Composition and method for self-assembly and mineralization of peptide-amphiphiles

#1445
20100216708
2010-08-26

Fibronectin type III domain based scaffold compositions, methods and uses

#1446
20100216173
2010-08-26

Citrullinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis

#1447
20100210822
2010-08-19

Modified recombinant human endostatin and uses thereof

#1448
20100184085
2010-07-22

Prokaryotic collage-like proteins and uses thereof

#1449
20100179094
2010-07-15

Bispecific EGFR/IGFIR binding molecules

#1450
20100173314
2010-07-08

DIAGNOSTIC METHODS USING TENASCIN-W COMPOSITIONS

#1451
20100172949
2010-07-08

Consensus peptides and a method for inducing biomineralization

#1452
20100172886
2010-07-08

Method for Promoting Wound Healing

#1453
20100168025
2010-07-01

Treatment of stroke using domain V of perlecan

#1454
20100155245
2010-06-24

Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer

#1455
20100152063
2010-06-17

Universal fibronectin Type III binding-domain libraries

#1456
20100151096
2010-06-17

Inhibition of ice crystal growth

#1457
20100150886
2010-06-17

Method of producing lymphocytes

#1458
20100144641
2010-06-10

Compositions Having Antiangiogenic Activity and Uses Thereof

#1459
20100144601
2010-06-10

Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses

#1460
20100144038
2010-06-10

Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell

#1461
20100143442
2010-06-10

GROWTH FACTOR COMPLEXES AND MODULATION OF CELL MIGRATION AND GROWTH

#1462
20100129288
2010-05-27

Gliomedin, Fragments Thereof and Methods of Using Same

#1463
20100121033
2010-05-13

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

#1464
20100119574
2010-05-13

Recombinant gelatins

#1465
20100119538
2010-05-13

Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof

#1466
20100105881
2010-04-29

Method for purifying marine collagen and the processing thereof into porous sponges

#1467
20100105876
2010-04-29

Method for the oligomerisation of peptides

#1468
20100105618
2010-04-29

Non-natural recombinant gelatins with enhanced functionality

#1469
20100105107
2010-04-29

PURIFICATION AND CHARACTERIZATION OF SOLUBLE MHC PROTEINS

#1470
20100099629
2010-04-22

Ophthalmological composition

#1471
20100099624
2010-04-22

Packaged product

#1472
20100099623
2010-04-22

Cross-Linked Collagen and Uses Thereof

#1473
20100099168
2010-04-22

Artificial antibody polypeptides

#1474
20100095387
2010-04-15

METHODS AND REAGENTS FOR SCREENING NEW DRUGS AND FOR TREATING ION PUMP ASSOCIATED DISORDERS AND DISEASES

#1475
20100092467
2010-04-15

Prevention of tissue ischemia, related methods and compositions

#1476
20100092395
2010-04-15

ACOUSTICALLY DELIVERING METHODS AND COMPOSITONS FOR REMOTE TREATMENT OF A TUMOR

#1477
20100088773
2010-04-08

MUTATIONS IN LAMA2 GENE OF ZEBRAFISH

#1478
20100077490
2010-03-25

Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy

#1479
20100075902
2010-03-25

Recombinant XRGD-enriched gelatins having high stability

#1480
20100069609
2010-03-18

CHEMICAL METHODS AND APPARATUS

#1481
20100068342
2010-03-18

COLLAGEN PEPTIDE COMPOSITION AND FOOD OR BEVERAGE CONTAINING THE SAME

#1482
20100063253
2010-03-11

Long-lasting collagen and manufacturing method thereof

#1483
20100062531
2010-03-11

RGD containing recombinant gelatin

#1484
20100062027
2010-03-11

Interaction of with epithelial cells, extracellular matrix proteins and the complement system

#1485
20100048477
2010-02-25

Method for prevention of platelet aggregation employing and RGD-enriched gelatine-like protein

#1486
20100036098
2010-02-11

Biocomposites and methods of making the same

#1487
20100035271
2010-02-11

Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions

#1488
20100034804
2010-02-11

Mutants of streptokinase and their covalently modified forms

#1489
20100029564
2010-02-04

Solubilized protein composition obtained from eggshell membrane

#1490
20100022755
2010-01-28

Platelet aggregation inducing substance

#1491
20100022746
2010-01-28

Synthesis of a radiofluorinated peptide using photolabile protecting groups

#1492
20100022455
2010-01-28

Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide

#1493
20100021527
2010-01-28

COLLAGEN-RELATED PEPTIDES AND USES THEREOF AND HEMOSTATIC FOAM SUBSTRATES

#1494
20100008964
2010-01-14

ISOLATED STROMAL CELLS AND METHODS OF USING THE SAME

#1495
20100004433
2010-01-07

NOVEL COLLAGEN-LIKE PROTEIN CLAC, PRECURSOR THEREOF AND GENES ENCODING THE SAME

#1496
20100004183
2010-01-07

Mineral collagen chelates and methods of making and using same

#1497
20090312243
2009-12-17

TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) WITH ANTI-ANGIOGENIC COMPOUNDS

#1498
20090305352
2009-12-10

Activated collagen scaffold materials and their special fused active restoration factors

#1499
20090304666
2009-12-10

CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF

#1500
20090299040
2009-12-03

Multivalent fibronectin based scaffold domain proteins